VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 142 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $100,000 | -40.1% | 10,100 | -34.3% | 0.00% | – |
| Q2 2022 | $167,000 | -37.7% | 15,372 | -35.2% | 0.00% | – |
| Q1 2022 | $268,000 | -15.7% | 23,704 | +16.8% | 0.00% | -100.0% |
| Q4 2021 | $318,000 | -73.6% | 20,300 | -71.1% | 0.00% | -75.0% |
| Q3 2021 | $1,203,000 | +158.7% | 70,139 | +224.5% | 0.00% | +100.0% |
| Q2 2021 | $465,000 | +72.9% | 21,617 | +31.9% | 0.00% | 0.0% |
| Q4 2019 | $269,000 | -57.4% | 16,388 | -32.2% | 0.00% | -60.0% |
| Q4 2018 | $632,000 | +229.2% | 24,180 | +187.9% | 0.01% | +400.0% |
| Q3 2018 | $192,000 | -86.8% | 8,400 | -91.2% | 0.00% | -85.7% |
| Q4 2017 | $1,453,000 | +24116.7% | 95,500 | +23775.0% | 0.01% | – |
| Q1 2017 | $6,000 | -98.8% | 400 | -98.8% | 0.00% | -100.0% |
| Q4 2016 | $510,000 | +7185.7% | 32,000 | +7900.0% | 0.00% | – |
| Q3 2016 | $7,000 | -81.6% | 400 | -91.1% | 0.00% | – |
| Q1 2016 | $38,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |